Urologie [Trends in urology]


Autoria(s): Uffer M.; Chollet Y.; Cardinaux C.; Erling C.; Praz V.; Ramadani D.; Tawadros T.; Treutherdt C.; Wisard M.; Zarkik Y.; Jichlinski P.
Data(s)

2008

Resumo

The systemic treatment of kidney cancers is promising regarding the first results of the inhibiting molecules of the angiogenesis. Projections in research are encouraging for more specific and sensitive markers of the prostate cancer. For this last the intermittent hormonotherapy improves the quality of life of the patients. The overweight control in infertility allows greater chances of giving birth. The morbidity of the kidney percutaneous surgery is decreased by the use of smaller tools. Reduction rate of reobstruction thanks to new manufactoring stents. The botulinic toxin for the hyperactive bladder refunded by the health insurances.

Identificador

http://serval.unil.ch/?id=serval:BIB_1CFE1C128485

isbn:1660-9379

pmid:18309882

Idioma(s)

fr

Fonte

Revue médicale suisse, vol. 4, no. 140, pp. 166-8

Palavras-Chave #Antigens, Neoplasm; Botulinum Toxin Type A; Humans; Male; Neuromuscular Agents; Stents; Urologic Diseases
Tipo

info:eu-repo/semantics/review

article